Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome.

International journal of molecular sciences - 30 Nov 2020

Lassalle Sandra, Nahon-Esteve Sacha, Frouin Eric, Boulagnon-Rombi Camille, Josselin Nicolas, Cassoux Nathalie, Barnhill Raymond, Scheller Boris, Baillif Stéphanie, Hofman Paul

Abstract excerpt

Conjunctival melanoma (CM) iss a rare and aggressive tumour that is increasing in frequency. The prognostic value of PD-L1 expression, alone or in combination with CD8 and PD-1 expression and the BRAF and NRAS status, has not been determined in CM to date. We evaluated the expression of PD-L1, CD8, PD-1 in CM and investigated whether there was an association between the expression of these markers and the BRAF...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Conjunctival Neoplasms
Share to Gene Expression

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunohistochemistry

Share to B7-H1 Antigen

Share to Biomarkers, Tumor

Share to CD8-Positive T-Lymphocytes

Share to Lymphocytes, Tumor-Infiltrating

Share to Melanoma

Source

Open in PubMed Open full text

Identifiers

PMID: 33266349
DOI: 10.3390/ijms21239147
PMCID: PMC7731195

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

PD-L1 Expression in 65 Conjunctival Melanomas and Its Association with Clinical Outcome.PMID 33266349Read ↗

Programmed Cell Death Ligand 1 Immunohistochemical Expression and Cutaneous Melanoma: A Controversial RelationshipSemantic proximity Read ↗

Conjunctival Melanoma: A Clinical Review and UpdateSemantic proximity Read ↗

PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristicsSemantic proximity Read ↗

Conjunctival malignant melanoma in Denmark: epidemiology, treatment and prognosis with special emphasis on tumorigenesis and genetic profile.Semantic proximity Read ↗

Conjunctival Melanoma: Current Treatments and Future Options.Semantic proximity Read ↗

MicroRNA Expression Profile in Conjunctival MelanomaSemantic proximity Read ↗

BRAF and NRAS prognostic values in conjunctival melanoma: analysis and literature review.Semantic proximity Read ↗

BRAF mutations in conjunctival melanoma: investigation of incidence, clinicopathological features, prognosis and paired premalignant lesions.Semantic proximity Read ↗

PD-L1 expression in melanocytic lesions does not correlate with the BRAF V600E mutation.Semantic proximity Read ↗

Correlation of MET and PD-L1 expression in malignant melanomaSemantic proximity Read ↗

Programmed cell death ligand 1 in correlation with BRAFV600E mutation, molecular characteristics and biological behavior in ameloblastoma.Semantic proximity Read ↗

PD-L1 Expression in colorectal carcinoma and its correlation with clinicopathological parameters, microsatellite instability and BRAF mutation.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.